West Pharmaceutical Services Stock Market Value
| WST Stock | USD 246.16 2.60 1.07% |
| Symbol | West |
Is there potential for Health Care Equipment & Supplies market expansion? Will West introduce new products? Factors like these will boost the valuation of West Pharmaceutical. Anticipated expansion of West directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about West Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.038 | Dividend Share 0.84 | Earnings Share 6.75 | Revenue Per Share | Quarterly Revenue Growth 0.077 |
Investors evaluate West Pharmaceutical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating West Pharmaceutical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause West Pharmaceutical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between West Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if West Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, West Pharmaceutical's market price signifies the transaction level at which participants voluntarily complete trades.
West Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to West Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of West Pharmaceutical.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in West Pharmaceutical on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding West Pharmaceutical Services or generate 0.0% return on investment in West Pharmaceutical over 90 days. West Pharmaceutical is related to or competes with Inspira Technologies, Biomerica, Heart Test, STRATA Skin, Aptevo Therapeutics, Advanced Biomed, and Burning Rock. West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drug... More
West Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure West Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess West Pharmaceutical Services upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 12.18 | |||
| Value At Risk | (3.58) | |||
| Potential Upside | 2.76 |
West Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for West Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as West Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use West Pharmaceutical historical prices to predict the future West Pharmaceutical's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.09) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of West Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
West Pharmaceutical February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 1.58 | |||
| Coefficient Of Variation | (1,531) | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.82 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.41) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 12.18 | |||
| Value At Risk | (3.58) | |||
| Potential Upside | 2.76 | |||
| Skewness | 0.2791 | |||
| Kurtosis | 2.66 |
West Pharmaceutical Backtested Returns
West Pharmaceutical shows Sharpe Ratio of -0.0329, which attests that the company had a -0.0329 % return per unit of risk over the last 3 months. West Pharmaceutical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out West Pharmaceutical's Standard Deviation of 2.19, mean deviation of 1.58, and Market Risk Adjusted Performance of (0.08) to validate the risk estimate we provide. The firm maintains a market beta of 1.73, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, West Pharmaceutical will likely underperform. At this point, West Pharmaceutical has a negative expected return of -0.0736%. Please make sure to check out West Pharmaceutical's maximum drawdown and rate of daily change , to decide if West Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.09 |
Very weak reverse predictability
West Pharmaceutical Services has very weak reverse predictability. Overlapping area represents the amount of predictability between West Pharmaceutical time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of West Pharmaceutical price movement. The serial correlation of -0.09 indicates that less than 9.0% of current West Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.09 | |
| Spearman Rank Test | -0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 333.94 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.